The global biologic excipient market is projected to be appraised at USD 2,241.8 million by 2034, up from USD 1500 million in 2024, advancing at a CAGR of 4.10% from 2024 to 2034.
The stabilization, solubilization, and improvement of biologic molecules' bioavailability are vital functions of biologic excipients, guaranteeing their safety and effectiveness during the production process and product lifespan.
Biotechnology breakthroughs, the growing biopharmaceutical pipeline, and the rising incidence of chronic illnesses are the main factors propelling the growth of the biologic excipients market.
The need for specialized excipients to improve the formulation and distribution of biologic drugs-which provide tailored therapy with fewer side effects-is being driven by the growing demand for these medications.
| Attributes | Key Insights |
|---|---|
| Market Size in 2024 | USD 1,500 million |
| Market Value in 2034 | USD 2,241.8 million |
| Value-based CAGR from 2024 to 2034 | 4.10% |
From 2019 to 2023, the biologic excipient market experienced a CAGR of 3.90%. Over the projected period, a robust growth rate is anticipated in the biologic excipients market. This is because, among other things, excipients are frequently used in the creation of novel treatments and have the ability to increase the solubility of active ingredients in pharmaceuticals.
Furthermore, two key factors that are anticipated to fuel the expansion of the biologic excipients market during the projected period are the ongoing advancements in drug delivery technology and the prevalence of inflammatory and autoimmune diseases.
The development of new regulations, more financing opportunities, and more public-private collaborations drive the expansion of creative collaborative research prospects in pediatric formulations.
The development of flexible, dispersible, and multifunctional biologic excipients for use in pediatric oral solid and liquid formulations has taken precedence.
In addition, it is anticipated that in the upcoming years, demand for these excipients and oral formulations will be driven by pediatricians' continuous emphasis on unmet medical requirements. Projections indicate that the global biologic excipient market is expected to experience a CAGR of 4.10% from 2024 to 2034.
| Historical CAGR from 2019 to 2023 | 3.90% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 4.10% |
This section will detail the biologic excipient markets in key countries, including the United States, Germany, the United Kingdom, China, and India. This sector will emphasize the various reasons propelling the growth of the biologic excipient market in the countries mentioned below.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 3.70% |
| Germany | 4.50% |
| The United Kingdom | 4.0% |
| China | 3.40% |
| India | 3.90% |
The biopharmaceutical sector in the United States is thriving, with many businesses producing, developing, and researching biologic medications. The need for specialized excipients to enhance the formulation and administration of biologic medicines is being driven by the rise in biotechnology investment and the number of biopharmaceutical businesses.
The biologic excipient market in the United States is expected to grow at a positive 3.70% CAGR over the assessment period.
Biologic medications are becoming more and more popular in the United States because of their ability to treat a wide range of complicated and chronic illnesses, including cancer, autoimmune diseases, and inflammatory problems.
Biologic medications are becoming more and more popular because they provide tailored therapy with fewer adverse effects than conventional small-molecule drugs. This has increased the demand for biologic excipients.
The United Kingdom is expected to surge at a 4.0%CAGR throughout the forecast period. In the fields of biotechnology and pharmaceuticals, scientific research and innovation are led by the United Kingdom.
United Kingdom companies and research organizations are actively developing novel excipients and drug delivery systems to enhance the efficacy and performance of biological medications.
Cutting-edge drug delivery technologies, including liposomes, nanoparticles, and polymer-based carriers, are driving up demand for specific excipients with special uses. The country's need for biologic excipients to enable the formulation and administration of biologic treatments is fueled in part by rising healthcare costs.
Germany is expected to surge at a 4.50%CAGR throughout the forecast period.
The growing aging population, the prevalence of chronic illnesses, and the availability of reputable facilities that offer high-quality care are the main factors driving the growth of the biologic excipients market in the country.
Furthermore, the German market will see a rise in demand for innovative excipients due to advantageous regulatory environments and rising investments in the development of biologics and sophisticated dosage forms.
The Chinese market is anticipated to hold a CAGR of 3.40% during the forecast period. The primary drivers of growth in China are the rise in R&D, instantaneously treating medications' availability, the healthcare sector's development, and the growing need for safe, effective medical practices and other therapies.
In addition, China has internal market influences, favorable government policies, changing regulations, and increasing funding, all of which impact both present and future market trends.
Biologic therapies are becoming increasingly well-liked among patients and healthcare professionals since they deliver customized treatments with better efficacy and safety profiles than traditional medications. The need for excipients that are specifically suited to their unique formulation needs is being driven by the growing market for biological medicines.
India's biologic excipient drug market is anticipated to hold a CAGR of 3.90% during the forecast period. The need for specialized excipients to enhance formulation and distribution has increased due to the rise of Indian biotech companies concentrating on developing biological drugs.
India's middle-class population and fast-increasing healthcare sector are driving up healthcare spending and driving up demand for novel cures.
Investment in biologic medications and excipients is fueled by government initiatives to increase insurance coverage and access to healthcare services. Excipients are in high demand as a means of facilitating the formulation and delivery of biologic medicines as a result of India's rising healthcare spending.
The section below shows the leading segment. The polymers segment is expected to account for a market share of 30.10% in 2024. Based on application, the electricity segment is expected to have a share of 34.50%.
| Category | Market Share |
|---|---|
| Polymers | 30.10% |
| Biopharmaceutical Manufacturers | 65.70% |
The polymers segment emerged as the dominant force in the biologic excipient market, commanding 30.10% of the total market share in 2024. Because polymer excipients can be customized to fit the unique needs of biological medicinal products, they provide formulation designers with a great deal of versatility.
Polymers are useful for a variety of biological formulations because they can be tailored to provide a range of capabilities, including enhanced solubility, controlled release, stability of proteins, and protection against degradation.
By altering the pharmacokinetics and release profile of biologic medications, polymer excipients allow for more regulated and prolonged drug delivery. Targeted delivery to particular tissues or organs can be achieved by adding polymers into drug formulations, extending the therapeutic impact and lowering the dosing frequency.
Based on end-users, the biopharmaceutical manufacturers segment is expected to account for a market share of 65.70% in 2024. Biopharmaceutical producers use excipients to enhance biologic drug pharmacokinetics and biodistribution, as well as to optimize drug delivery systems.
Excipients have the potential to increase tissue targeting, reduce systemic adverse effects, and modify the kinetics of drug release, all of which can improve patient compliance and therapeutic outcomes.
The development of cutting-edge drug delivery systems, such as sustained-release formulations, liposomal carriers, and nanoparticle formulations, depends heavily on biologic excipients. To guarantee product safety, efficacy, and quality, regulatory bodies like the FDA and EMA place strict restrictions on the use of excipients in biologic medication formulations.
Manufacturers of biopharmaceuticals are required to choose excipients that meet regulatory requirements and provide proof of their compatibility through extensive testing and validation procedures.
Faster market entry and commercialization are made possible by excipients with known safety profiles and regulatory approvals, which streamline the regulatory approval process for biologic therapeutic products.
Companies in the biologic excipients industry are actively looking to bolster their positions through collaborations and acquisitions with established and up-and-coming competitors. Excipients are being produced in large quantities at local facilities by the manufacturers, who then sell them to biological drug producers at extremely low costs.
Leading companies in the field are concentrating on developing biologic excipients. Adopting IPEC principles is anticipated to encourage adherence to protocols, improving medicine efficacy and product safety in manufacturing and distribution.
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | USD 1,500 million |
| Projected Market Valuation in 2034 | USD 2,241.8 million |
| Value-based CAGR 2024 to 2034 | 4.10% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in USD million |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa |
| Key Market Segments Covered | Excipients Type, End Users, Region |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key Companies Profiled | FMC Corporation; Wacker Chemie AG; Evonik Industries AG; Ashland Global Holdings Inc.; Archer-Daniels-Midland Co.; Roquette Freres S.A.; The Dow Chemical Company; Colorcon Inc.; Signet Chemical Co. Pvt. Ltd.; Sun Pharmaceutical Industries Ltd |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (Tons) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Excipient Type, 2019 to 2034
Table 4: Global Market Volume (Tons) Forecast by Excipient Type, 2019 to 2034
Table 5: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 6: Global Market Volume (Tons) Forecast by End User, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 8: North America Market Volume (Tons) Forecast by Country, 2019 to 2034
Table 9: North America Market Value (US$ Million) Forecast by Excipient Type, 2019 to 2034
Table 10: North America Market Volume (Tons) Forecast by Excipient Type, 2019 to 2034
Table 11: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 12: North America Market Volume (Tons) Forecast by End User, 2019 to 2034
Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Latin America Market Volume (Tons) Forecast by Country, 2019 to 2034
Table 15: Latin America Market Value (US$ Million) Forecast by Excipient Type, 2019 to 2034
Table 16: Latin America Market Volume (Tons) Forecast by Excipient Type, 2019 to 2034
Table 17: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 18: Latin America Market Volume (Tons) Forecast by End User, 2019 to 2034
Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 20: Western Europe Market Volume (Tons) Forecast by Country, 2019 to 2034
Table 21: Western Europe Market Value (US$ Million) Forecast by Excipient Type, 2019 to 2034
Table 22: Western Europe Market Volume (Tons) Forecast by Excipient Type, 2019 to 2034
Table 23: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 24: Western Europe Market Volume (Tons) Forecast by End User, 2019 to 2034
Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: Eastern Europe Market Volume (Tons) Forecast by Country, 2019 to 2034
Table 27: Eastern Europe Market Value (US$ Million) Forecast by Excipient Type, 2019 to 2034
Table 28: Eastern Europe Market Volume (Tons) Forecast by Excipient Type, 2019 to 2034
Table 29: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 30: Eastern Europe Market Volume (Tons) Forecast by End User, 2019 to 2034
Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 32: South Asia and Pacific Market Volume (Tons) Forecast by Country, 2019 to 2034
Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Excipient Type, 2019 to 2034
Table 34: South Asia and Pacific Market Volume (Tons) Forecast by Excipient Type, 2019 to 2034
Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 36: South Asia and Pacific Market Volume (Tons) Forecast by End User, 2019 to 2034
Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 38: East Asia Market Volume (Tons) Forecast by Country, 2019 to 2034
Table 39: East Asia Market Value (US$ Million) Forecast by Excipient Type, 2019 to 2034
Table 40: East Asia Market Volume (Tons) Forecast by Excipient Type, 2019 to 2034
Table 41: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 42: East Asia Market Volume (Tons) Forecast by End User, 2019 to 2034
Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 44: Middle East and Africa Market Volume (Tons) Forecast by Country, 2019 to 2034
Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Excipient Type, 2019 to 2034
Table 46: Middle East and Africa Market Volume (Tons) Forecast by Excipient Type, 2019 to 2034
Table 47: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 48: Middle East and Africa Market Volume (Tons) Forecast by End User, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Excipient Type, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 5: Global Market Volume (Tons) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ Million) Analysis by Excipient Type, 2019 to 2034
Figure 9: Global Market Volume (Tons) Analysis by Excipient Type, 2019 to 2034
Figure 10: Global Market Value Share (%) and BPS Analysis by Excipient Type, 2024 to 2034
Figure 11: Global Market Y-o-Y Growth (%) Projections by Excipient Type, 2024 to 2034
Figure 12: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 13: Global Market Volume (Tons) Analysis by End User, 2019 to 2034
Figure 14: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 15: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 16: Global Market Attractiveness by Excipient Type, 2024 to 2034
Figure 17: Global Market Attractiveness by End User, 2024 to 2034
Figure 18: Global Market Attractiveness by Region, 2024 to 2034
Figure 19: North America Market Value (US$ Million) by Excipient Type, 2024 to 2034
Figure 20: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 21: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 22: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 23: North America Market Volume (Tons) Analysis by Country, 2019 to 2034
Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 26: North America Market Value (US$ Million) Analysis by Excipient Type, 2019 to 2034
Figure 27: North America Market Volume (Tons) Analysis by Excipient Type, 2019 to 2034
Figure 28: North America Market Value Share (%) and BPS Analysis by Excipient Type, 2024 to 2034
Figure 29: North America Market Y-o-Y Growth (%) Projections by Excipient Type, 2024 to 2034
Figure 30: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 31: North America Market Volume (Tons) Analysis by End User, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 34: North America Market Attractiveness by Excipient Type, 2024 to 2034
Figure 35: North America Market Attractiveness by End User, 2024 to 2034
Figure 36: North America Market Attractiveness by Country, 2024 to 2034
Figure 37: Latin America Market Value (US$ Million) by Excipient Type, 2024 to 2034
Figure 38: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 39: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 40: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 41: Latin America Market Volume (Tons) Analysis by Country, 2019 to 2034
Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 44: Latin America Market Value (US$ Million) Analysis by Excipient Type, 2019 to 2034
Figure 45: Latin America Market Volume (Tons) Analysis by Excipient Type, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Excipient Type, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Excipient Type, 2024 to 2034
Figure 48: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 49: Latin America Market Volume (Tons) Analysis by End User, 2019 to 2034
Figure 50: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 51: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 52: Latin America Market Attractiveness by Excipient Type, 2024 to 2034
Figure 53: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 54: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 55: Western Europe Market Value (US$ Million) by Excipient Type, 2024 to 2034
Figure 56: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 57: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 58: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 59: Western Europe Market Volume (Tons) Analysis by Country, 2019 to 2034
Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 62: Western Europe Market Value (US$ Million) Analysis by Excipient Type, 2019 to 2034
Figure 63: Western Europe Market Volume (Tons) Analysis by Excipient Type, 2019 to 2034
Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Excipient Type, 2024 to 2034
Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Excipient Type, 2024 to 2034
Figure 66: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 67: Western Europe Market Volume (Tons) Analysis by End User, 2019 to 2034
Figure 68: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 70: Western Europe Market Attractiveness by Excipient Type, 2024 to 2034
Figure 71: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 72: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 73: Eastern Europe Market Value (US$ Million) by Excipient Type, 2024 to 2034
Figure 74: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 75: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 76: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 77: Eastern Europe Market Volume (Tons) Analysis by Country, 2019 to 2034
Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 80: Eastern Europe Market Value (US$ Million) Analysis by Excipient Type, 2019 to 2034
Figure 81: Eastern Europe Market Volume (Tons) Analysis by Excipient Type, 2019 to 2034
Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Excipient Type, 2024 to 2034
Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Excipient Type, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 85: Eastern Europe Market Volume (Tons) Analysis by End User, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 88: Eastern Europe Market Attractiveness by Excipient Type, 2024 to 2034
Figure 89: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 90: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 91: South Asia and Pacific Market Value (US$ Million) by Excipient Type, 2024 to 2034
Figure 92: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 93: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 94: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 95: South Asia and Pacific Market Volume (Tons) Analysis by Country, 2019 to 2034
Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 98: South Asia and Pacific Market Value (US$ Million) Analysis by Excipient Type, 2019 to 2034
Figure 99: South Asia and Pacific Market Volume (Tons) Analysis by Excipient Type, 2019 to 2034
Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Excipient Type, 2024 to 2034
Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Excipient Type, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 103: South Asia and Pacific Market Volume (Tons) Analysis by End User, 2019 to 2034
Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 106: South Asia and Pacific Market Attractiveness by Excipient Type, 2024 to 2034
Figure 107: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 108: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 109: East Asia Market Value (US$ Million) by Excipient Type, 2024 to 2034
Figure 110: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 111: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 112: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 113: East Asia Market Volume (Tons) Analysis by Country, 2019 to 2034
Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 116: East Asia Market Value (US$ Million) Analysis by Excipient Type, 2019 to 2034
Figure 117: East Asia Market Volume (Tons) Analysis by Excipient Type, 2019 to 2034
Figure 118: East Asia Market Value Share (%) and BPS Analysis by Excipient Type, 2024 to 2034
Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Excipient Type, 2024 to 2034
Figure 120: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 121: East Asia Market Volume (Tons) Analysis by End User, 2019 to 2034
Figure 122: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 123: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 124: East Asia Market Attractiveness by Excipient Type, 2024 to 2034
Figure 125: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 126: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 127: Middle East and Africa Market Value (US$ Million) by Excipient Type, 2024 to 2034
Figure 128: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 129: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 130: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 131: Middle East and Africa Market Volume (Tons) Analysis by Country, 2019 to 2034
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Excipient Type, 2019 to 2034
Figure 135: Middle East and Africa Market Volume (Tons) Analysis by Excipient Type, 2019 to 2034
Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Excipient Type, 2024 to 2034
Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Excipient Type, 2024 to 2034
Figure 138: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 139: Middle East and Africa Market Volume (Tons) Analysis by End User, 2019 to 2034
Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 142: Middle East and Africa Market Attractiveness by Excipient Type, 2024 to 2034
Figure 143: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 144: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
As of 2024, the market for biologic excipient is expected to be valued at USD 1,500 million.
By 2034, the market value of biologic excipient is expected to reach USD 2,214.8 million.
From 2024 to 2034, the biologic excipient market is expected to flourish at a CAGR of 4.10%.
The polymers segment is expected to account for a market share of 30.10% in 2024.
Germany is likely the top-performing markets, with a CAGR of 4.50%.
Explore Similar Insights
Biologic Excipient Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
